These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 2676666
1. Small intestinal morphology in experimental diabetic rats: a stereological study on the effects of an aldose reductase inhibitor (ponalrestat) given with or without conventional insulin therapy. Mayhew TM, Carson FL, Sharma AK. Diabetologia; 1989 Sep; 32(9):649-54. PubMed ID: 2676666 [Abstract] [Full Text] [Related]
2. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition. Zoubi SA, Williams MD, Mayhew TM, Sparrow RA. Virchows Arch; 1995 Sep; 427(2):187-93. PubMed ID: 7582250 [Abstract] [Full Text] [Related]
3. Responses of enterocyte microvilli in experimental diabetes to insulin and an aldose reductase inhibitor (ponalrestat). Williams M, Mayhew TM. Virchows Arch B Cell Pathol Incl Mol Pathol; 1992 Sep; 62(6):385-9. PubMed ID: 1360726 [Abstract] [Full Text] [Related]
4. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy. Bhoyrul S, Sharma AK, Stribling D, Mirrlees DD, Peterson RG, Farber MO, Thomas PK. J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441 [Abstract] [Full Text] [Related]
5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG. Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023 [Abstract] [Full Text] [Related]
6. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Chakrabarti S, Sima AA. Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638 [Abstract] [Full Text] [Related]
7. Mechanisms of adaptation in rat small intestine: regional differences in quantitative morphology during normal growth and experimental hypertrophy. Mayhew TM, Carson FL. J Anat; 1989 Jun; 164():189-200. PubMed ID: 2532638 [Abstract] [Full Text] [Related]
8. Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. Belai A, Calcutt NA, Carrington AL, Diemel LT, Tomlinson DR, Burnstock G. J Auton Nerv Syst; 1996 May 06; 58(3):163-9. PubMed ID: 8738309 [Abstract] [Full Text] [Related]
9. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy. Umeda F, Noda K, Hashimoto T, Yamashita T, Nawata H. Diabetes Res; 1989 Nov 06; 12(3):125-9. PubMed ID: 2561396 [Abstract] [Full Text] [Related]
10. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. Ekström AR, Tomlinson DR. J Neurol Sci; 1989 Nov 06; 93(2-3):231-7. PubMed ID: 2531788 [Abstract] [Full Text] [Related]
11. Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition. Cameron NE, Cotter MA, Robertson S. Diabetologia; 1989 Jun 06; 32(6):365-70. PubMed ID: 2503412 [Abstract] [Full Text] [Related]
12. Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat. Pekiner C, McLean WG. Br J Pharmacol; 1990 Dec 06; 101(4):978-80. PubMed ID: 2128196 [Abstract] [Full Text] [Related]
13. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB, Calcutt NA, Tomlinson DR. Diabetologia; 1987 Apr 06; 30(4):239-43. PubMed ID: 2439402 [Abstract] [Full Text] [Related]
14. Effects of ponalrestat on depressor responses to arachidonic acid in streptozotocin-diabetic rats. Law SC, King RG. Gen Pharmacol; 1990 Apr 06; 21(1):135-9. PubMed ID: 2105258 [Abstract] [Full Text] [Related]
15. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Yagihashi S, Kamijo M, Ido Y, Mirrlees DJ. Diabetes; 1990 Jun 06; 39(6):690-6. PubMed ID: 2140802 [Abstract] [Full Text] [Related]
16. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor]. Terubayashi H, Akagi Y, Takahashi Y, Ikebe H, Miyamoto Y, Ibaraki N, Yokoi N, Tutumi M, Itoi M. Nippon Ganka Gakkai Zasshi; 1988 Jan 06; 92(1):151-5. PubMed ID: 3133928 [No Abstract] [Full Text] [Related]
17. Comparison of sorbinil and ponalrestat (Statil) diminution of proteinuria in the BB rat. Beyer-Mears A, Murray FT, Cruz E, Rountree J, Sciadini M. Pharmacology; 1992 Jan 06; 45(5):285-91. PubMed ID: 1465475 [Abstract] [Full Text] [Related]
18. Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia. Cameron NE, Cotter MA, Robertson S. Diabetes; 1990 Apr 06; 39(4):460-5. PubMed ID: 2108070 [Abstract] [Full Text] [Related]
19. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Taylor PD, Wickenden AD, Mirrlees DJ, Poston L. Br J Pharmacol; 1994 Jan 06; 111(1):42-8. PubMed ID: 8012723 [Abstract] [Full Text] [Related]
20. Structural and functional characteristics of muscle from diabetic rodent small intestine. Nowak TV, Harrington B, Weisbruch JP, Kalbfleisch JH. Am J Physiol; 1990 May 06; 258(5 Pt 1):G690-8. PubMed ID: 2185667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]